PubRank

Shinji Shimoda

Author PubWeight™ 75.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. J Hepatol 2012 2.91
2 Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 2012 2.30
3 Accuracy in measurement of distance using limited cone-beam computerized tomography. Int J Oral Maxillofac Implants 2004 2.14
4 B cell activation regulates exosomal HLA production. Eur J Immunol 2008 1.78
5 The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS One 2008 1.76
6 Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006 1.53
7 Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005 1.37
8 Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 2012 1.32
9 Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 2005 1.28
10 Characteristics of accessory mental foramina observed on limited cone-beam computed tomography images. J Endod 2008 1.24
11 Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J 2006 1.20
12 The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptor-mediated signaling required for systemic growth. PLoS One 2011 1.18
13 Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006 1.12
14 Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology 2005 1.08
15 Liver architecture, cell function, and disease. Semin Immunopathol 2009 1.06
16 T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol 2009 1.06
17 T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005 1.03
18 Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy. J Hepatol 2013 1.03
19 Anatomical characteristics of the mandibular lingual foramina observed on limited cone-beam CT images. Clin Oral Implants Res 2009 1.03
20 Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005 1.03
21 Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 2003 1.02
22 Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 2012 1.02
23 Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C. J Hepatol 2013 1.00
24 Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol 2013 1.00
25 T cell immunity and graft-versus-host disease (GVHD). Autoimmun Rev 2005 0.99
26 Accuracy of intraoral radiography, multidetector helical CT, and limited cone-beam CT for the detection of horizontal tooth root fracture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009 0.96
27 Detection of buccal perimandibular neurovascularisation associated with accessory foramina using limited cone-beam computed tomography and gross anatomy. Surg Radiol Anat 2010 0.96
28 Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 2007 0.93
29 Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006 0.92
30 Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group. J Gastroenterol Hepatol 2008 0.92
31 Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol 2009 0.91
32 Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells. FASEB J 2004 0.90
33 Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011 0.90
34 Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C. World J Gastroenterol 2010 0.89
35 Guidelines for therapy of autoimmune liver disease. Semin Liver Dis 2007 0.88
36 Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies. J Infect Chemother 2012 0.88
37 Accuracy of oral mucosal thickness measurements using spiral computed tomography. J Periodontol 2010 0.87
38 Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology 2011 0.87
39 Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J Autoimmun 2005 0.87
40 Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver Int 2013 0.87
41 CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells. Blood 2012 0.86
42 Human cord blood--derived cells generate insulin-producing cells in vivo. Stem Cells 2005 0.86
43 Risk factors and prediction of long-term outcome in primary biliary cirrhosis. Intern Med 2011 0.86
44 Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group. World J Gastroenterol 2006 0.85
45 Serum BAFF and APRIL levels in patients with PBC. Clin Immunol 2009 0.85
46 Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 2005 0.85
47 Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2010 0.84
48 Effects of functional monomers and photo-initiators on the degree of conversion of a dental adhesive. Acta Biomater 2012 0.84
49 T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 2005 0.84
50 Mandibular lingual canals distribute to the dental crypts in prenatal stage. Surg Radiol Anat 2013 0.84
51 Intracellular B7-H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis. Inflammation 2011 0.83
52 Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res 2010 0.83
53 Is primary biliary cirrhosis a model autoimmune disease? Autoimmun Rev 2004 0.83
54 Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma. Liver Int 2007 0.83
55 Body surface area is an independent factor contributing to the effects of lamivudine treatment. Hepatol Res 2004 0.83
56 Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study. World J Gastroenterol 2006 0.81
57 T cell immunity and primary biliary cirrhosis. Autoimmun Rev 2003 0.81
58 The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C. Hepatogastroenterology 2014 0.80
59 Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study. J Gastroenterol Hepatol 2012 0.80
60 Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J Immunol 2007 0.80
61 Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis. Int Heart J 2005 0.79
62 Vigorous cleaning and adequate ventilation are necessary to control an outbreak in a neonatal intensive care unit. J Infect Chemother 2011 0.79
63 Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosis. Liver Int 2010 0.79
64 Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J Autoimmun 2003 0.79
65 Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PLoS One 2013 0.79
66 The immune response to mitochondrial autoantigens. Semin Liver Dis 2005 0.79
67 Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comp Hepatol 2007 0.78
68 [A case of diffuse hepatic arteriovenous fistulae with hepatic encephalopathy, postprandial abdominal pain and biliary injury]. Nihon Shokakibyo Gakkai Zasshi 2009 0.78
69 Time-lapse observation of rat periodontal ligament during function and tooth movement, using microcomputed tomography. Eur J Orthod 2008 0.78
70 Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol Res 2007 0.78
71 Impact of conversion from pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation. Transplantation 2013 0.77
72 Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase. Hepatol Res 2011 0.77
73 Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis. Clin Rev Allergy Immunol 2005 0.76
74 [Pathogenesis of biliary tract injury in primary biliary cirrhosis]. Nihon Rinsho Meneki Gakkai Kaishi 2012 0.76
75 An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. J Infect Chemother 2012 0.76
76 Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era. Am J Hematol 2012 0.76
77 Relationship between body surface area and ALT normalization after long-term lamivudine treatment. World J Gastroenterol 2005 0.76
78 Clinicopathological significance of serum fractalkine in primary biliary cirrhosis. Dig Dis Sci 2013 0.75
79 Drug-induced Liver Injury Associated with Mosapride Citrate: A Report of Two Cases. Intern Med 2017 0.75
80 Thromboxane-dependent portopulmonary hypertension. Am J Med 2005 0.75
81 Infective endocarditis caused by Listeria monocytogenes forming a pseudotumor. Intern Med 2014 0.75
82 Two cases of malignant lymphoma with reactivation of resolved hepatitis B virus infection after bendamustine hydrochloride monotherapy. Nihon Shokakibyo Gakkai Zasshi 2016 0.75
83 Bone augmentation around a dental implant using demineralized bone sheet containing biologically active substances. Dent Mater J 2016 0.75
84 Nondestructive examination of all-ceramic fixed partial denture with microcomputed tomography. J Prosthet Dent 2003 0.75
85 [Bilateral Granulomatous Renal Masses after Intravesical BCG Therapy for Non-muscle-invasive Bladder Cancer and Carcinoma in Situ of the Upper Urinary Tract: A Case Study]. Kansenshogaku Zasshi 2015 0.75
86 [A case of advanced malignant melanoma with multiple metastases to the liver and the gastrointestinal tract]. Nihon Shokakibyo Gakkai Zasshi 2007 0.75
87 Alteration of energy metabolism in the pathogenesis of bile duct lesions in primary biliary cirrhosis. J Clin Pathol 2013 0.75
88 Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus. Intern Med 2017 0.75
89 [A case of drug-induced liver injury caused by Keishi-karyukotsu-boreito and Shin-i-seihaito]. Nihon Shokakibyo Gakkai Zasshi 2015 0.75
90 Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection. Intern Med 2015 0.75
91 [Autoimmune liver diseases and related afflictions--factors responsible for their development]. Nihon Naika Gakkai Zasshi 2006 0.75
92 Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. J Gastroenterol Hepatol 2014 0.75
93 [Recent topics on PBC. Discussion]. Nihon Shokakibyo Gakkai Zasshi 2013 0.75
94 [Case of hepatic hydrothorax occurring rapidly after rehabilitation]. Nihon Shokakibyo Gakkai Zasshi 2009 0.75
95 Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living-donor liver transplantation. Hepatol Res 2012 0.75
96 Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance. J Med Microbiol 2014 0.75